Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms
Open Access
- 1 May 2018
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 178 (5) , 681-690
Abstract
An estimated 40% to 54% of postmenopausal women report bothersome vulvovaginal symptoms,1-3 including vaginal dryness (up to 75%) and pain with intercourse (40%).2,4,5 In 2014, the North American Menopause Society coined the term genitourinary syndrome of menopause (GSM) to reflect the multifaceted nature of this prevalent problem, replacing genitourinary and vulvovaginal atrophy.6 Recent evidence shows decrements in quality of life from moderate to severe vulvovaginal symptoms in women aged 40 to 75 years comparable to those caused by other chronic conditions such as arthritis, chronic obstructive pulmonary disease, and irritable bowel syndrome.1 Yet more than half of symptomatic women are not using any medication to treat their symptoms.7,8Keywords
This publication has 48 references indexed in Scilit:
- Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioningMaturitas, 2017
- A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data reviewMaturitas, 2017
- The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its TreatmentThe Journal of Sexual Medicine, 2017
- Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH AnalysisSexual Medicine, 2015
- Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophyMaturitas, 2013
- Women's voices in the menopause: Results from an international survey on vaginal atrophyMaturitas, 2010
- Characterization of the Rheological, Mucoadhesive, and Drug Release Properties of Highly Structured Gel Platforms for Intravaginal Drug DeliveryBiomacromolecules, 2009
- Screening for Depression in Medical Settings with the Patient Health Questionnaire (PHQ): A Diagnostic Meta-AnalysisJournal of General Internal Medicine, 2007
- Local oestrogen for vaginal atrophy in postmenopausal women2006
- Local estrogen treatment in patients with urogenital symptomsInternational Journal of Gynecology & Obstetrics, 2003